Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company’s principal business lines are focused on the production, distribution and sale of cannabis and cannabis-derivative products in Canada and internationally, and the propagation of vegetables and ornamental plants in North America. Its segments include Canadian Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Drift, San Rafael '71, Daily Special, Tasty's, Being and Greybeard. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol, IndiMed and CraftPlant. It also has a controlling interest in Bevo Farms Ltd., North America's supplier of propagated vegetables and ornamental plants in North America. Its subsidiaries include Aurora Cannabis Enterprises Inc., Aurora Deutschland GmbH, TerraFarma Inc., Whistler Medical Marijuana Corporation, and Indica Industries Pty Ltd., among others.


TSX:ACB - Post by User

Bullboard Posts
Comment by oilcan2012on May 12, 2020 2:55pm
121 Views
Post# 31018513

RE:I called it a day

RE:I called it a day
  1. Peltz put his name on Aurora which is the only likely reason he remains interested;  salvaging his brand/track record which would likely be a key concern. He has warrants he can exercise at $~10.00 contingent on ACB's SP hitting $~30 which is meaningless. So, how far will he go?
  2. Balance Sheet- further impairment write downs are on the horizon, goodwill at min will likely exceed $1 billion. Subsequently, could there be inventory/other impairment adjustments?
  3. Debt- one could only guess the pressures being placed on Aurora operations by its lenders. Covenants breached? Who knows but is that a likelihood?. In any event, what are the prospects of a financial institution granting more credit to Aurora?  Therefore, put the batteries in the printing press, produce more certs/dilution and screw shareholders more than they have already. 
A super-competent CEO may belay market attitudes towards Aurora but given the shape of the balance sheet, who would want to take that on WITHOUT a super-deal with an outside investor/manager such as Mondelez? Then, there is the investment portfolio, its relevancy/profitability and if not, how board oversight at the outset played a role in the MASSIVE impairment write-downs that have, and need to occur. 

Thursday is a critical day for Aurora. 
Bullboard Posts